{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:31:16Z","timestamp":1792276276597,"version":"4.4.0"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.8774-16","type":"journal-article","created":{"date-parts":[[2017,9,24]],"date-time":"2017-09-24T22:08:41Z","timestamp":1506290921000},"page":"3103-3107","source":"Crossref","is-referenced-by-count":19,"title":["Ceftriaxone-induced Neurotoxicity in a Patient after Pancreas-Kidney Transplantation"],"prefix":"10.2169","volume":"56","author":[{"given":"Hideharu","family":"Hagiya","sequence":"first","affiliation":[{"name":"Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Osaka University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihisa","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadafumi","family":"Asaoka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Akeda","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Tomono","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Patel I, Sugihara J, Weinfeld R, Wong E, Siemsen A, Berman S. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment. Antimicrob Agents Chemother 25: 438-442, 1984.","DOI":"10.1128\/AAC.25.4.438"},{"key":"2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1592\/phco.26.8.1169","volume":"26","author":"S Lam","year":"2006","unstructured":"2. Lam S, Gomolin IH. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review. Pharmacotherapy 26: 1169-1174, 2006.","journal-title":"Pharmacotherapy Official Journal of the American College of Clinical Pharmacy","ISSN":"https:\/\/id.crossref.org\/issn\/0277-0008","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kim S-Y, Lee I-S, Park SL, Lee J. Cefepime neurotoxicity in patients with renal insufficiency. Ann Rehabil Med 36: 159-162, 2012.","DOI":"10.5535\/arm.2012.36.1.159"},{"key":"4","unstructured":"4. Chow K, Hui A, Szeto C. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. Eur J Clin Microbiol Infect Dis 24: 649-653, 2005."},{"key":"5","unstructured":"5. Grill MF, Maganti R. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. Ann Pharmacother 42: 1843-1850, 2008."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mart\u00ednez-Rodr\u00edguez JE, Barriga FJ, Santamaria J, et al. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med 111: 115-119, 2001.","DOI":"10.1016\/S0002-9343(01)00767-7"},{"key":"7","unstructured":"7. Roncon-Albuquerque Jr R, Pires I, Martins R, Real R, Sousa G, von Hafe P. Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection. Neth J Med 67: 72-75, 2009."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sato Y, Morita H, Wakasugi H, et al. Reversible chreoathetosis after the administration of ceftriaxone sodium in patients with end-stage renal disease. Am J Med Sci 340: 382-384, 2010.","DOI":"10.1097\/MAJ.0b013e3181ec063b"},{"key":"9","unstructured":"9. Kim KB, Kim SM, Park W, Kim JS, Kwon SK, Kim H-Y. Ceftiaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review. J Korean Med Sci 27: 1120-1123, 2012."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sharma N, Batish S, Gupta A. Ceftriaxone-induced acute reversible encephalopathy in a patient with enteric fever. Indian J Pharmacol 44: 124, 2012.","DOI":"10.4103\/0253-7613.91884"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Safadi S, Mao M, Dillon JJ. Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient. Case Rep Nephrol 2014: 108185, 2014.","DOI":"10.1155\/2014\/108185"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Marco S, Cecilia F, Patrizia B. Neurologic complications after solid organ transplantation. Transpl Int 22: 269-278, 2009.","DOI":"10.1111\/j.1432-2277.2008.00780.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pruitt AA, Graus F, Rosenfeld MR. Neurological complications of solid organ transplantation. Neurohospitalist 3: 152-166, 2013.","DOI":"10.1177\/1941874412466090"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Bhattacharyya S, Darby RR, Raibagkar P, Castro LNG, Berkowitz AL. Antibiotic-associated encephalopathy. Neurology 86: 963-971, 2016.","DOI":"10.1212\/WNL.0000000000002455"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wallace KL. Antibiotic-induced convulsions. Crit Care Clin 13: 741-762, 1997.","DOI":"10.1016\/S0749-0704(05)70367-5"},{"key":"16","unstructured":"16. Schliamser SE, Cars O, Norrby SR. Neurotoxicity of \u0392-lactam antibiotics: predisposing factors and pathogenesis. J Antimicrob Chemother 27: 405-425, 1991."},{"key":"17","unstructured":"17. Calandra G, Lydick E, Carrigan J, Weiss L, Guess H. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem\/cilastatin. Am J Med 84: 911-918, 1988."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/22\/56_8774-16\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T22:32:21Z","timestamp":1570141941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/22\/56_8774-16\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":17,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8774-16","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}